Implications for the role of endogenous nitric oxide inhibitors in hemodialysis hypotension.
Hypotensive episodes during hemodialysis in patients with end-stage renal disease in the absence of inadequate maintenance of the plasma volume, pre-existence of cardiovascular disease, or autonomic nervous system dysfunction is accompanied by increase in the plasma concentrations of the end-products of nitric oxide metabolism, above the levels expected based on the reduction of urea. Factors that can influence the synthesis of nitric oxide or the regulation of the effects of this free radical in patients with chronic renal failure are reviewed. Convergence of these factors and their interactions during the hemodialysis procedure are discussed as the basis for the generation of excessive amounts of nitric oxide that serves as an important contributing factor in the development of symptomatic hypotension.
Kang
E S
ES
Departments of Pediatrics, Pharmacology, University of Tennessee College of Medicine, Memphis, Tennessee, USA.
Acchiardo
S R
SR
Kang
A H
AH
D004791:Enzyme Inhibitors / Q000378:metabolism; D006801:Humans; D007022:Hypotension / Q000209:etiology / Q000378:metabolism*; D007676:Kidney Failure, Chronic / Q000628:therapy; D009569:Nitric Oxide / Q000037:antagonists & inhibitors* / Q000378:metabolism; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors; D006435:Renal Dialysis
D004791:Enzyme Inhibitors; D009569:Nitric Oxide; D019001:Nitric Oxide Synthase